Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
37.41
-0.42 (-1.11%)
At close: Jun 18, 2026
SHA:603014 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:603014 stock has a consensus rating of "Strong Buy" and an average price target of ¥44.25. The average 1-year stock price forecast is 18.28% higher than the current stock price, while the lowest is ¥42.00 (+12.27%) and the highest is ¥46.50 (+24.30%).
Price Target: ¥44.25 (+18.28%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:603014 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 3 |
Financial Forecast
Revenue This Year
4.07B
from 3.77B
Increased by 7.86%
Revenue Next Year
4.45B
from 4.07B
Increased by 9.52%
EPS This Year
1.17
from 1.17
EPS Next Year
1.32
from 1.17
Increased by 12.82%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.1B | ||
| Avg | 4.1B | ||
| Low | 4.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.8% | ||
| Avg | 7.9% | ||
| Low | 6.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.17 | ||
| Avg | 1.17 | ||
| Low | 1.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |